Building on your basic understanding of USP’s approach to dissolution, this course provides a foundation for developing and validating dissolution, disintegration and drug release methods used in product development, batch release and stability testing. These tests are in vitro performance tests for dosage forms, such as tablets, capsules, suspensions, transdermal patches and suppositories. They are important components of the specifications that establish the strength, quality, purity and bioavailability of a drug product. On the second day, real case studies will be discussed in an interactive group activity.
Date: December 13, 14, 15 and 16, 2021
Couse Duration (hh:mm:ss): 12:00:00
Margareth Marques, Ph.D – USP Principal Scientific Liaison